Italia markets closed
FTSE MIB
33.629,21 -107,19 (-0,32%) Dow Jones
38.675,68 +450,02 (+1,18%) Nasdaq
16.156,33 +315,37 (+1,99%) Nikkei 225
38.236,07 -37,98 (-0,10%) Petrolio
77,99 -0,96 (-1,22%) Bitcoin EUR
58.888,57 +181,00 (+0,31%)
DaVita Inc. (0I7E.L)
LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
Alla chiusura: 07:02PM BST
| Chiusura precedente | 142,57 |
| Aperto | 138,26 |
| Denaro | 0,00 x 0 |
| Lettera | 0,00 x 0 |
| Min-Max giorno | 131,82 - 143,00 |
| Intervallo di 52 settimane | 71,57 - 143,00 |
| Volume | |
| Media Volume | 1.554 |
| Capitalizzazione | 223,236M |
| Beta (5 anni mensile) | 1,05 |
| Rapporto PE (ttm) | 0,16 |
| EPS (ttm) | 8,46 |
| Prossima data utili | 01 ago 2024 - 05 ago 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
GlobeNewswireNuwellis Inc. Announces Pilot Agreement With DaVita Inc.
Supply Agreement to Pilot Ultrafiltration Therapy Services Offering in Select MarketsMINNEAPOLIS, June 20, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced it has entered into a Supply and Collaboration Agreement with DaVita Inc. (NYSE: DVA) to pilot Aquadex ultrafiltration therapy to treat adult patients with congestive heart failure and related conditions within select U.S. mark
© 2024 Yahoo. Tutti i diritti riservati.